These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23629625)

  • 1. SAD-A potentiates glucose-stimulated insulin secretion as a mediator of glucagon-like peptide 1 response in pancreatic β cells.
    Nie J; Lilley BN; Pan YA; Faruque O; Liu X; Zhang W; Sanes JR; Han X; Shi Y
    Mol Cell Biol; 2013 Jul; 33(13):2527-34. PubMed ID: 23629625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAD-A Promotes Glucose-Stimulated Insulin Secretion Through Phosphorylation and Inhibition of GDIα in Male Islet β Cells.
    Nie J; Sun C; Chang Z; Musi N; Shi Y
    Endocrinology; 2018 Aug; 159(8):3036-3047. PubMed ID: 29873699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
    Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
    J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.
    Nie J; Sun C; Faruque O; Ye G; Li J; Liang Q; Chang Z; Yang W; Han X; Shi Y
    J Biol Chem; 2012 Jul; 287(31):26435-44. PubMed ID: 22669945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitic acid acutely inhibits acetylcholine- but not GLP-1-stimulated insulin secretion in mouse pancreatic islets.
    Doliba NM; Qin W; Vinogradov SA; Wilson DF; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E475-85. PubMed ID: 20606076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
    Liu L; Wang F; Lu H; Ren X; Zou J
    Islets; 2014; 6(4):e962386. PubMed ID: 25437377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1.
    Peyot ML; Nolan CJ; Soni K; Joly E; Lussier R; Corkey BE; Wang SP; Mitchell GA; Prentki M
    Diabetes; 2004 Jul; 53(7):1733-42. PubMed ID: 15220197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
    J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
    Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
    Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
    Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAD-A, a downstream mediator of GLP-1 signaling, promotes the phosphorylation of Bad S155 to regulate in vitro β-cell functions.
    Wang K; Liu D; Zhang Y; Chang X; Xu R; Pang J; Li K; Sun P; Zhu Y; Han X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):76-81. PubMed ID: 30573363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.
    Peyot ML; Gray JP; Lamontagne J; Smith PJ; Holz GG; Madiraju SR; Prentki M; Heart E
    PLoS One; 2009 Jul; 4(7):e6221. PubMed ID: 19593440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling.
    Nie J; Liu X; Lilley BN; Zhang H; Pan YA; Kimball SR; Zhang J; Zhang W; Wang L; Jefferson LS; Sanes JR; Han X; Shi Y
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13857-62. PubMed ID: 23922392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
    Laychock SG
    Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1.
    Jacobo SM; Guerra ML; Hockerman GH
    J Pharmacol Exp Ther; 2009 Nov; 331(2):724-32. PubMed ID: 19710366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snapin mediates incretin action and augments glucose-dependent insulin secretion.
    Song WJ; Seshadri M; Ashraf U; Mdluli T; Mondal P; Keil M; Azevedo M; Kirschner LS; Stratakis CA; Hussain MA
    Cell Metab; 2011 Mar; 13(3):308-19. PubMed ID: 21356520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
    Yan S; Conley JM; Reilly AM; Stull ND; Abhyankar SD; Ericsson AC; Kono T; Molosh AI; Kubal CA; Evans-Molina C; Ren H
    Cell Rep; 2022 Jan; 38(1):110179. PubMed ID: 34986353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.